C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
01/2007
01/02/2007	US7157475 Diamide invertebrate pest control agents
01/02/2007	US7157464 Substituted piperazines
01/02/2007	US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
12/2006
12/28/2006	WO2006138453A2 Compositions and methods pertaining to pna synthons and oligomers comprising a universal base
12/28/2006	WO2006138373A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
12/28/2006	WO2006138148A1 Pesticidal 5-bis(methoxymethyl)aminopyrazole derivatives
12/28/2006	WO2006138147A1 Pesticidal 5-di-(substituted)aminopyrazole derivatives
12/28/2006	WO2006136830A1 Aryl-alkylamines and heteroaryl-alkylamines as protein kinase inhibitors
12/28/2006	WO2006136829A2 Pyrazole derivatives and their use as pka and pkb modulators
12/28/2006	WO2006136821A1 Pharmaceutical compounds
12/28/2006	WO2006136529A1 Pyrazolium alkylsulfates as ionic liquids
12/28/2006	WO2006136288A1 Method for producing carboxamides
12/28/2006	WO2006136287A1 Method for producing carboxamides
12/28/2006	WO2006135978A1 Antiviral compounds and methods
12/28/2006	WO2006060211A3 Pyrazole derivatives for the treatment of sexual dysfunction
12/28/2006	WO2006058648A3 Biaryloxymethylarene carboxylic acids
12/28/2006	WO2006056873A3 Therapeutic pyrazolo[3,4-b] pyridines and indazoles
12/28/2006	WO2006009902A3 Non-natural amino acids
12/28/2006	US20060293347 Pharmaceutically active compounds
12/28/2006	US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme
12/28/2006	CA2612403A1 Antiviral compounds and methods
12/28/2006	CA2612075A1 Crystalline modifications to pyraclostrobin
12/27/2006	EP1735319A1 Inhibitors of histone deacetylase
12/27/2006	EP1735286A1 Tetrahydro-indazole cannabinoid modulators
12/27/2006	EP1735285A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
12/27/2006	EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
12/27/2006	EP1735283A1 Herbicidal 3-amino-2-thiomethyl benzoyl pyrazoles
12/27/2006	EP1735282A1 Pyrazole compounds and uses related thereto
12/27/2006	EP1735268A1 Opioid receptor antagonists
12/27/2006	EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
12/27/2006	EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
12/27/2006	EP1187826B1 Heterocyclic derivatives useful as anticancer agents
12/27/2006	EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006	CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/27/2006	CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups
12/27/2006	CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors
12/27/2006	CN1291650C Method of purifying a pesticide
12/26/2006	US7154002 Phenylglycinamide derivatives containing a substituent capable of complexing with a protein metal ion, particularly an acrylhydroxamic group, e.g., 3-(3-{Benzylcarbamoyl-[formyl-(4-phenoxy-phenyl)-amino]-methyl}-phenyl)-N-hydroxy-acrylamide; antiproliferative agents
12/26/2006	US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006	US7153880 Substituted diphenyl heterocycles useful for treating HCV infection
12/26/2006	US7153871 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153813 Substituted aryl ketones
12/21/2006	WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	WO2006134468A1 Substituted arylpyrazoles for use against parasitites
12/21/2006	WO2006134459A1 Substituted arylpyrazoles
12/21/2006	WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators
12/21/2006	WO2006133634A1 Tetrahydroindole derivatives and tetrahydroindazole derivatives, and use thereof
12/21/2006	WO2006115626A3 Process for the preparation of ultrapure 4-methylprazole
12/21/2006	WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	US20060287526 Alkylating a 3-aminopyrazole-4-carbonitrile with a halo acetate, reacting with formamide or urea, or with the secondary nitrogen of a substituted or unsubstituted N-(2-aminoethyl)glycine moiety to cyclize and form 8-aza-7-deazaadenine base
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287365 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; parasiticides; fleas; Extended duration of action for at least 28 days
12/21/2006	DE102005028533A1 New pyrazolium alkyl sulfate useful as solvents for chemical reactions, and heat carrier
12/21/2006	DE102005028294A1 Preparation of a carboxamide compound comprises reacting 5-fuoro-1,3-dimethyl-1H-pyrazol-4-carboxylicacidfluoride with an aniline derivative in the presence of an acid acceptor
12/21/2006	CA2611979A1 Substituted arylpyrazoles
12/21/2006	CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/20/2006	EP1734082A1 Monoazo/iron complex compound, charge control agent comprising the same, and toner
12/20/2006	EP1734081A1 Azo compound, ink composition, and colored object
12/20/2006	EP1732900A2 Acrylonitrile derivatives for inflammation and immune-related uses
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1732865A1 Fluoridation method
12/20/2006	EP1732560A1 Substituted cinnolin-4-ylamines
12/20/2006	EP1732541A2 Cyclic compounds
12/20/2006	EP1670458B1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
12/20/2006	EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882857A Filter for electronic display
12/20/2006	CN1882564A Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
12/20/2006	CN1882527A Biphenyloxy-acids
12/20/2006	CN1880317A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7150876 Methods for stabilizing ingredients within cosmetics, personal care and household products
12/14/2006	WO2006131807A1 Preparation of 3-amino-4,5-disubstituted-pyrazole derivatives
12/14/2006	WO2006081554A3 Phenyl-substituted pyrrolidones
12/14/2006	WO2005110428A3 Resistance-repellent retroviral protease inhibitors
12/14/2006	US20060281803 Pyrazole modulators of metabotropic glutamate receptors
12/14/2006	US20060281789 Protein kinase inhibitors
12/14/2006	US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006	US20060281686 Aza-peptides
12/14/2006	CA2611124A1 Synthesis of 3-amino-4-substituted pyrazole derivatives
12/13/2006	EP1731509A1 Process for producing nitrogenous 5-membered cyclic compound
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730141A1 Compounds for the treatment of diseases
12/13/2006	EP1730116A1 4-carbox pyrazole derivates useful as anti-viral agents
12/13/2006	EP1730115A1 5-aminoalkylpyrazole derivatives as pesticidal agents
12/13/2006	EP1730099A2 Mitotic kinesin inhibitors
12/13/2006	EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006	CN1878549A Percutaneous absorption type cerebral protective agent
12/13/2006	CN1876664A Organometallic complex and organic electroluminescent device using the same
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006	CN1289460C Aryl-acrylic acid esters
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7147937 Organic element for electroluminescent devices
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative

1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 256